Insider Trading: Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

8.52USD
31 Jul 2015
Change (% chg)

$0.13 (+1.55%)
Prev Close
$8.39
Open
$8.43
Day's High
$8.59
Day's Low
$8.33
Volume
1,264,632
Avg. Vol
3,176,323
52-wk High
$16.87
52-wk Low
$6.76

Search Stocks
All Insider Trades
Trading Date Name Title Type Shares Traded Price
18 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 814,860 $11.50
18 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 327,713 $11.65
18 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 5,900 $11.84
18 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 16,387 $11.67
10 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 531,352 $12.31
10 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 83,560 $12.62
10 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 83,560 $12.62
10 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 184,643 $12.41
10 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 184,643 $12.41
10 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 115,000 $12.33
10 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 17,357 $12.32
10 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 115,000 $12.33
10 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 531,352 $12.31
10 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 250,000 $12.35
10 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 17,357 $12.32
10 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 250,000 $12.35
9 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 69,833 $12.63
9 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 273,017 $12.70
9 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 69,833 $12.63
9 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 49,057 $12.69
9 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 273,017 $12.70
9 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 8,600 $12.73
9 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 121,943 $12.61
9 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 49,057 $12.69
9 Sep 2014

RA CAPITAL MANAGEMENT L L C

Beneficial Owner of More than 10% Class Sell 8,600 $12.73

Institutional Holders

% Shares Owned: 97.17%
# of Holders: 224
Total Shares Held: 114,229,362
3 Mo. Net Change: 4,203,563
# New Positions: 7
# Closed Positions: 6
# Increased Positions: 15
# Reduced Positions: 16
# Net Buyers: -1

Officers & Directors

Name Age Since Current Position

David Scheer

62 2010 Chairman of the Board

Milind Deshpande

58 2013 President, Chief Executive Officer, Director

Mary Fenton

51 2010 Chief Financial Officer, Senior Vice President

David Apelian

49 2013 Executive Vice President, Chief Medical Officer

Joseph Truitt

50 2014 Executive Vice President, Chief Commercial Officer

Michael Kishbauch

66 2013 Director

Jason Fisherman

58 2000 Independent Director

Gary Frashier

78 2008 Independent Director

Kurt Graves

47 2012 Independent Director

Robert Van Nostrand

58 2007 Independent Director

Nicole Vitullo

58 2010 Independent Director
Search Stocks